Trial Details
RECRUITINGBasic Information
| Clinical ID | c1584 |
|---|---|
| Identifier | NCT06488625 |
| Trial Title | Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients with Mild to Moderately Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis, Unspecified |
| Interventions | DRUG: Low-Dose CICR-NAM|DRUG: High-Dose CICR-NAM|DRUG: 0 g/d CICR-NAM (blinded)|DRUG: Open-Label |
Participant Information
| Sponsor | University Hospital Schleswig-Holstein |
|---|---|
| City | Kiel |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2024-09-12 |
|---|---|
| Primary Completion Date | 2025-10-27 |
| Completion Date | 2025-12-27 |